EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Selection determines therapeutic effects: a retrospective analysis of the application of different frailty tools in elderly patients with multiple myeloma

Yujun Li, Songying Zhao, Jianmei Xu, Jiangbo Zhang, Jing Wang, Huimei Guo, Liyang Liu, Hua Xue

Discover Oncology · 10.10.2024 · 15 (1)

DOI: 10.1007/s12672-024-01305-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 10.10.2024. Verfasst von Yujun Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Qian Xi Nan People's Hospital, Xingyi, 562400, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The aim was to explore the effectiveness of the International Myeloma Working Group Frailty Index (IMWG-FI), Mayo Score, UK Myeloma Research Alliance Risk Profile (MRP), and Intergroupe Francophone du Myélome (IFM) simplified frailty scale for classifying frailty in elderly multiple myeloma (MM) patients and compare the validity of different frailty tools. METHODS: Eighty-four newly diagnosed MM patients aged ≥ 60 years in HeBei University Hospital were evaluated by the IMWG-FI, Mayo score, MRP score and IFM scale, and consistency and survival analyses were performed using Cohen's kappa coefficients and the Kaplan‒Meier method, respectively. RESULTS: A total of 64 patients (76.2%) were identified as frail by at least one frailty tool; 14 (21.9%) were identified as frail by all four tools, and although moderate concordance was achieved between the IMWG-FI and MRP and the Mayo Score (0.432-0.474, P < 0.001), the concordance among the four assessment tools was relatively low (Cohen's kappa 0.218-0.474). The median overall survival (OS, P = 0.006, 0.025, and 0.028) and progression-free survival (PFS, P = 0.002, 0.006, and 0.03) of patients in the frail group and the nonfrail group identified by the IMWG-FI, Mayo score, and MRP were significantly different, while the median OS (P = 0.139) and PFS (P = 0.167) were not significantly different for the frail patients identified by the different frailty assessment tools. CONCLUSION: In this study, the consistency of the different frailty assessment tools was low, whereas that between the MRP and IMWG-FI was high. Therefore, combining IMWG-FI and MRP may reduce assessment subjectivity and improve frailty identification.

Schlagwörter

Stichwörter der Autor:innen

FrailtyGeriatric assessmentMultiple myelomaPrognosis

Autor:innen und Institutionen

  • Qian Xi Nan People's Hospital, Xingyi, 562400, China.
  • Department of Hematology, Affiliated Hospital of Hebei University, Baoding, 071000, Hebei, China.
  • Department of Hematology, Affiliated Hospital of Hebei University, Baoding, 071000, Hebei, China. xh-xuehua@163.com.

Zitieren

APA

Li, Y., Zhao, S., Xu, J., Zhang, J., Wang, J., Guo, H., Liu, L., & Xue, H. (2024). Selection determines therapeutic effects: a retrospective analysis of the application of different frailty tools in elderly patients with multiple myeloma. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01305-5

Vancouver

Li Y, Zhao S, Xu J, Zhang J, Wang J, Guo H, et al. Selection determines therapeutic effects: a retrospective analysis of the application of different frailty tools in elderly patients with multiple myeloma. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01305-5

BibTeX
@article{Li2024,
  author = {Li, Yujun and Zhao, Songying and Xu, Jianmei and Zhang, Jiangbo and Wang, Jing and Guo, Huimei and Liu, Liyang and Xue, Hua},
  title = {Selection determines therapeutic effects: a retrospective analysis of the application of different frailty tools in elderly patients with multiple myeloma},
  journal = {Discover Oncology},
  year = {2024},
  volume = {15},
  number = {1},
  doi = {10.1007/s12672-024-01305-5}
}
Kostenlos starten →